Sonoma Biotherapeutics
Biotechnology Research
South San Francisco, California 13,887 followers
Leading the Next Frontier of Cell Therapy
Our Leadership
Everyone on our leadership team has a rich and diverse history
Mission & Vision
At Sonoma Bio, we’re not content with just making incremental change. Our mission is simple: design, develop and deliver engineered regulatory T cell (Treg) therapies to cure autoimmune and inflammatory disease and transform patients’ lives. Our innovative scientific approach, capabilities and talented team are the engine that drives our vision, all fueled by our commitment to rebalance the immune system and radically change the lives of patients with these diseases.
Learn More About Our PurposeOur Values
At Sonoma Bio, we're Driven by Science, Collaborative, Pioneering, Focused on Cures and Committed to Diversity and a Sense of Belonging. We believe that innovation requires the collaboration of many people working together, and the most critical insights can come from anyone in the organization. We will strive to create an environment where all voices are heard. Our collective goals are more important than individual accomplishment. Together we will strive to make the most of our work.
Our ValuesJoin Our Team
Our balanced approach to treating and possibly curing autoimmune and inflammatory disease is similar to our approach to creating a healthy work environment. We collaborate with empathy. We balance new ideas and perspectives with experience and know-how. We recognize and champion differences by valuing and respecting other perspectives, ensuring all team members feel included and informed.
Careers at Sonoma BioCompany photos
Employee perspectives
-
The time is now: Autoimmune and inflammatory diseases, meet regulatory T-cell therapy
The time is now: Autoimmune and inflammatory diseases, meet regulatory T-cell therapy
By Jeffrey Bluestone
The immune system is a delicate, dynamic organ system. In February 2020, I launched Sonoma Biotherapeutics with the urgent mission to reprogram…
-
The Task Ahead: Translating Cell Therapy into Curative Medicines for Autoimmune Disease
The Task Ahead: Translating Cell Therapy into Curative Medicines for Autoimmune Disease
By Jeffrey Bluestone
For decades, academia and the biopharma industry have been delivering scientific innovation and, consequently, new therapies to millions of…